Back to Trades
Fein Seymour Howard
CRO/CMOCIK 0002147180
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Fein Seymour Howard, CRO/CMO, has filed 1 SEC report (2026), all concentrated in Oncotelic Therapeutics, Inc. (OTLC), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Jul 23 | OTLC Oncotelic Therapeutics, Inc. | Fein Seymour Howard | CRO/CMO | Award | $0 |
1 filing